The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Molecular Diagnostics-Global Market Insights and Sales Trends 2024
Synopsis
Molecular diagnostics market employs a range of systems, including real-time PCR systems, liquid handling systems, and DNA extraction systems, among others. Real-time PCR systems are commonly known as quantitative PCR systems. These systems monitor the amplification of the targeted DNA molecule during the exponential phase. The commonly used detection methods in these systems include fluorescent dyes and sequence specific DNA probes.
The global Molecular Diagnostics market size is expected to reach US$ 20730 million by 2029, growing at a CAGR of 8.6% from 2023 to 2029. The market is mainly driven by the significant applications of Molecular Diagnostics in various end use industries. The expanding demands from the Hospitals, Diagnostic Laboratories, Academic and Research Institutes and Pharmaceutical and Biotechnology Companies, are propelling Molecular Diagnostics market. Real Time- PCR Systems, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Liquid Handling System segment is estimated at % CAGR for the next seven-year period.
The basic components of these systems include thermal cycler for automating the temperature cycling required in the PCR; optical systems for detection; and software to control the instrument and analyze the data. Liquid handling systems are used to dispense selected quantity of reagents, liquids, or samples to a container. These systems work on the principle of suction and are available as single or multi-channel systems. DNA Extraction systems are employed for streamlining the process of DNA extraction and automatic extraction of DNA from a variety of samples. These systems are employed as they are less time consuming, more efficient than the manual methods, and less prone to analytical errors.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Molecular Diagnostics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Molecular Diagnostics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Molecular Diagnostics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Molecular Diagnostics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Molecular Diagnostics covered in this report include Agilent Technologies, BD, Bio-Rad Laboratories, Danaher, F. Hoffmann-La Roche, Eppendorf, PerkinElmer, Tecan Group and Thermo Fisher Scientific, etc.
The global Molecular Diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Agilent Technologies
BD
Bio-Rad Laboratories
Danaher
F. Hoffmann-La Roche
Eppendorf
PerkinElmer
Tecan Group
Thermo Fisher Scientific
QIAGEN
Global Molecular Diagnostics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Molecular Diagnostics market, Segment by Type:
Real Time- PCR Systems
Liquid Handling System
NA Extraction System
Global Molecular Diagnostics market, by Application
Hospitals
Diagnostic Laboratories
Academic and Research Institutes
Pharmaceutical and Biotechnology Companies
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Molecular Diagnostics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Molecular diagnostics market employs a range of systems, including real-time PCR systems, liquid handling systems, and DNA extraction systems, among others. Real-time PCR systems are commonly known as quantitative PCR systems. These systems monitor the amplification of the targeted DNA molecule during the exponential phase. The commonly used detection methods in these systems include fluorescent dyes and sequence specific DNA probes.
The global Molecular Diagnostics market size is expected to reach US$ 20730 million by 2029, growing at a CAGR of 8.6% from 2023 to 2029. The market is mainly driven by the significant applications of Molecular Diagnostics in various end use industries. The expanding demands from the Hospitals, Diagnostic Laboratories, Academic and Research Institutes and Pharmaceutical and Biotechnology Companies, are propelling Molecular Diagnostics market. Real Time- PCR Systems, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Liquid Handling System segment is estimated at % CAGR for the next seven-year period.
The basic components of these systems include thermal cycler for automating the temperature cycling required in the PCR; optical systems for detection; and software to control the instrument and analyze the data. Liquid handling systems are used to dispense selected quantity of reagents, liquids, or samples to a container. These systems work on the principle of suction and are available as single or multi-channel systems. DNA Extraction systems are employed for streamlining the process of DNA extraction and automatic extraction of DNA from a variety of samples. These systems are employed as they are less time consuming, more efficient than the manual methods, and less prone to analytical errors.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Molecular Diagnostics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Molecular Diagnostics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Molecular Diagnostics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Molecular Diagnostics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Molecular Diagnostics covered in this report include Agilent Technologies, BD, Bio-Rad Laboratories, Danaher, F. Hoffmann-La Roche, Eppendorf, PerkinElmer, Tecan Group and Thermo Fisher Scientific, etc.
The global Molecular Diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Agilent Technologies
BD
Bio-Rad Laboratories
Danaher
F. Hoffmann-La Roche
Eppendorf
PerkinElmer
Tecan Group
Thermo Fisher Scientific
QIAGEN
Global Molecular Diagnostics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Molecular Diagnostics market, Segment by Type:
Real Time- PCR Systems
Liquid Handling System
NA Extraction System
Global Molecular Diagnostics market, by Application
Hospitals
Diagnostic Laboratories
Academic and Research Institutes
Pharmaceutical and Biotechnology Companies
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Molecular Diagnostics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Molecular Diagnostics
1.1 Molecular Diagnostics Market Overview
1.1.1 Molecular Diagnostics Product Scope
1.1.2 Molecular Diagnostics Market Status and Outlook
1.2 Global Molecular Diagnostics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Molecular Diagnostics Market Size by Region (2018-2029)
1.4 Global Molecular Diagnostics Historic Market Size by Region (2018-2023)
1.5 Global Molecular Diagnostics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Molecular Diagnostics Market Size (2018-2029)
1.6.1 North America Molecular Diagnostics Market Size (2018-2029)
1.6.2 Europe Molecular Diagnostics Market Size (2018-2029)
1.6.3 Asia-Pacific Molecular Diagnostics Market Size (2018-2029)
1.6.4 Latin America Molecular Diagnostics Market Size (2018-2029)
1.6.5 Middle East & Africa Molecular Diagnostics Market Size (2018-2029)
2 Molecular Diagnostics Market by Type
2.1 Introduction
2.1.1 Real Time- PCR Systems
2.1.2 Liquid Handling System
2.1.3 NA Extraction System
2.2 Global Molecular Diagnostics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Molecular Diagnostics Historic Market Size by Type (2018-2023)
2.2.2 Global Molecular Diagnostics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Molecular Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Molecular Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Molecular Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Molecular Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Molecular Diagnostics Revenue Breakdown by Type (2018-2029)
3 Molecular Diagnostics Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Diagnostic Laboratories
3.1.3 Academic and Research Institutes
3.1.4 Pharmaceutical and Biotechnology Companies
3.2 Global Molecular Diagnostics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Molecular Diagnostics Historic Market Size by Application (2018-2023)
3.2.2 Global Molecular Diagnostics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Molecular Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Molecular Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Molecular Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Molecular Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Molecular Diagnostics Revenue Breakdown by Application (2018-2029)
4 Molecular Diagnostics Competition Analysis by Players
4.1 Global Molecular Diagnostics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Molecular Diagnostics as of 2022)
4.3 Date of Key Players Enter into Molecular Diagnostics Market
4.4 Global Top Players Molecular Diagnostics Headquarters and Area Served
4.5 Key Players Molecular Diagnostics Product Solution and Service
4.6 Competitive Status
4.6.1 Molecular Diagnostics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Agilent Technologies
5.1.1 Agilent Technologies Profile
5.1.2 Agilent Technologies Main Business
5.1.3 Agilent Technologies Molecular Diagnostics Products, Services and Solutions
5.1.4 Agilent Technologies Molecular Diagnostics Revenue (US$ Million) & (2018-2023)
5.1.5 Agilent Technologies Recent Developments
5.2 BD
5.2.1 BD Profile
5.2.2 BD Main Business
5.2.3 BD Molecular Diagnostics Products, Services and Solutions
5.2.4 BD Molecular Diagnostics Revenue (US$ Million) & (2018-2023)
5.2.5 BD Recent Developments
5.3 Bio-Rad Laboratories
5.3.1 Bio-Rad Laboratories Profile
5.3.2 Bio-Rad Laboratories Main Business
5.3.3 Bio-Rad Laboratories Molecular Diagnostics Products, Services and Solutions
5.3.4 Bio-Rad Laboratories Molecular Diagnostics Revenue (US$ Million) & (2018-2023)
5.3.5 Danaher Recent Developments
5.4 Danaher
5.4.1 Danaher Profile
5.4.2 Danaher Main Business
5.4.3 Danaher Molecular Diagnostics Products, Services and Solutions
5.4.4 Danaher Molecular Diagnostics Revenue (US$ Million) & (2018-2023)
5.4.5 Danaher Recent Developments
5.5 F. Hoffmann-La Roche
5.5.1 F. Hoffmann-La Roche Profile
5.5.2 F. Hoffmann-La Roche Main Business
5.5.3 F. Hoffmann-La Roche Molecular Diagnostics Products, Services and Solutions
5.5.4 F. Hoffmann-La Roche Molecular Diagnostics Revenue (US$ Million) & (2018-2023)
5.5.5 F. Hoffmann-La Roche Recent Developments
5.6 Eppendorf
5.6.1 Eppendorf Profile
5.6.2 Eppendorf Main Business
5.6.3 Eppendorf Molecular Diagnostics Products, Services and Solutions
5.6.4 Eppendorf Molecular Diagnostics Revenue (US$ Million) & (2018-2023)
5.6.5 Eppendorf Recent Developments
5.7 PerkinElmer
5.7.1 PerkinElmer Profile
5.7.2 PerkinElmer Main Business
5.7.3 PerkinElmer Molecular Diagnostics Products, Services and Solutions
5.7.4 PerkinElmer Molecular Diagnostics Revenue (US$ Million) & (2018-2023)
5.7.5 PerkinElmer Recent Developments
5.8 Tecan Group
5.8.1 Tecan Group Profile
5.8.2 Tecan Group Main Business
5.8.3 Tecan Group Molecular Diagnostics Products, Services and Solutions
5.8.4 Tecan Group Molecular Diagnostics Revenue (US$ Million) & (2018-2023)
5.8.5 Tecan Group Recent Developments
5.9 Thermo Fisher Scientific
5.9.1 Thermo Fisher Scientific Profile
5.9.2 Thermo Fisher Scientific Main Business
5.9.3 Thermo Fisher Scientific Molecular Diagnostics Products, Services and Solutions
5.9.4 Thermo Fisher Scientific Molecular Diagnostics Revenue (US$ Million) & (2018-2023)
5.9.5 Thermo Fisher Scientific Recent Developments
5.10 QIAGEN
5.10.1 QIAGEN Profile
5.10.2 QIAGEN Main Business
5.10.3 QIAGEN Molecular Diagnostics Products, Services and Solutions
5.10.4 QIAGEN Molecular Diagnostics Revenue (US$ Million) & (2018-2023)
5.10.5 QIAGEN Recent Developments
6 North America
6.1 North America Molecular Diagnostics Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Molecular Diagnostics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Molecular Diagnostics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Molecular Diagnostics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Molecular Diagnostics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Molecular Diagnostics Market Dynamics
11.1 Molecular Diagnostics Industry Trends
11.2 Molecular Diagnostics Market Drivers
11.3 Molecular Diagnostics Market Challenges
11.4 Molecular Diagnostics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
